ORGANOGENESIS HOLDINGS INC. Operating Lease, Liability, Current
ORGANOGENESIS HOLDINGS INC. (ORGO) had Operating Lease, Liability, Current of $3.81 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $3.81M.
- 2026-03-31: Operating Lease, Liability, Current $4.76M.
- 2025-12-31: Operating Lease, Liability, Current $4.95M.
- 2025-09-30: Operating Lease, Liability, Current $4.79M.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.81M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.76M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.95M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $4.79M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.80M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.35M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $4.27M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.93M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.08M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.67M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.73M 10-K · filed 2025-02-27 | $10.00M 10-K · filed 2024-02-29 |
| 2023-09-30 | $13.05M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.59M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $12.16M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $8.71M 10-K · filed 2024-02-29 | $11.71M 10-K · filed 2023-03-01 |
| 2022-09-30 | $12.15M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $11.87M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $11.78M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $11.79M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $4.67M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $4.00M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |